Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.

@article{Jones2011ProfilingTE,
  title={Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.},
  author={Paul W. Jones and Donald A. Mahler and Rupert Gale and Roger Owen and Benjamin Kramer},
  journal={Respiratory medicine},
  year={2011},
  volume={105 6},
  pages={892-9}
}
BACKGROUND Indacaterol is a novel, inhaled, ultra-long-acting β(2)-agonist bronchodilator for maintenance use in patients with COPD. The aim of this paper is to assess the effect of indacaterol on dyspnoea and health status, using pooled study data to evaluate the relative efficacy of indacaterol and existing bronchodilators. METHODS Individual patient data were pooled from three randomized, placebo-controlled studies (NCT00393458; NCT00567996; NCT00463567), conducted in patients with… CONTINUE READING

From This Paper

Topics from this paper.
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…